Oculomics for the Next Billion
The Eye as the World’s First Scalable Health Operating System

Healthcare today fails because we lack early, continuous, population-scale signals that can help risk triage those needing care.

Explore

Request a solution Learn More

Who are we?

Remidio is an innovative, (ISO 13485, MDSAP, IEC 27001, SOC 2 Type 2) certified health tech company that aims to impact preventable blindness with accessible, smart, and easy-to-use solutions that enable early detection of eye diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration.
‍
Remidio’s CE-marked and FDA 510(K) cleared devices have helped screen and impact more than 16+ million patients across 55+ countries.
‍
Remidio's portfolio of solutions includes portable, high-end devices and multimodal ophthalmic devices that are integrated with teleophthalmology software and edge artificial intelligence solutions.

Our Vision

Simplifying Healthcare
‍

Our Mission

We thrive on preventing blindness, preserving vision, preserving good health and touching a billion lives through simple, innovative and easy to use products.

Global Impact

4000

Devices worldwide

16

M+

Patients Screened

55

Countries Served

80

Research Publications

35

Patents Filed

What our customers say

Every product we develop has a tremendous amount of input from clinicians and other healthcare workers. Their feedback helps us ensure a simple to use, high-quality imaging experience. FOP helped our customers to image more than ten million patients in the last five years.

“Remidio’s products are a good fit to have in terms of ease of use and operational cost. Keep up the good work with innovative products.”

Delia Cabrera DeBuc, Ph.D

Associate Professor, Bascom Palmer Eye Institute. Miami

“I've been closely following a few of the products developed by Remidio for the last decade. Some of their technology, especially the Fundus On Phone, is very actively used in our vision centers. This device helps us a lot in preventing needless blindness among our patients.”

Dr. R. Venkatesh

CMO-Aravind Eye Hospital,
Pondicherry

“The IRIS - Remidio partnership in the US has had a powerful impact on healthcare providers seeking to close care gaps and create better outcomes for their patients with diabetes. The Remidio device is portable, and takes high quality images making it much easier to provide sight-saving exams to patients with diabetes, in primary care and at home..”

Steve Martin

CEO, Intelligent Retinal Imaging Systems (IRIS),
Florida

170+ Employees in 3 Global Locations

We have a highly dynamic team that loves to work closely with our customers and co-create with our partners. As a group, we dream and work together to make healthcare accessible.

Remidio India

Peenya Industrial Area, Phase-I, Bangalore, Karnataka, India
Postal Code: 560 058

Remidio Inc

11357 Nuckols Road #102
Glen Allen, VA 23059

Medios Technologies

59 New Bridge Road, Singapore
059405

Oculomics for the Next Billion
The Eye as the World’s First Scalable Health Operating System

Preventing needless blindness. Enabling life care through the eye, powered by AI

Who are we?

Our Vision

Our Mission

Global Impact

4000

16

55

80

35

We are backed by marquee VC, Angel and impact investors

Our Journey So Far